Asset Management in Pharma & Lifesciences: Benchmarking Performance

In this GARPI™ webinar, we explore how Pharma and Life Sciences manufacturers can better measure asset performance, reliability and operational risk beyond compliance evidence alone. While GMP, validation, SOPs and audit records are essential, they do not always prove that assets are delivering reliable operational outcomes. This session looks at the “performativity gap”, the space between what an organisation says it does through documented systems, and what actually happens in day-to-day asset performance. The webinar introduces GARPI™, the Global Asset Reliability & Performance Index, an ISO 55001-aligned benchmark designed to help organisations assess asset management maturity across eight dimensions, including asset performance outcomes, governance, maintenance strategy, digital capability, lifecycle value, workforce capability, supply chain readiness and risk resilience. For Pharma and Life Sciences leaders, this is a practical discussion about connecting engineering, quality, operations, supply chain and finance around a clearer view of asset performance, reliability risk and improvement priorities. In this webinar, we cover: • Why compliance evidence does not automatically prove reliable performance • How validated assets can still fail, drift or create operational risk • The performativity gap in Pharma and Life Sciences manufacturing • How GARPI™ benchmarks asset performance and asset management maturity • Early benchmark insights and what they suggest for industry leaders • How organisations can use benchmarking to prioritise improvement actions Take the GARPI™ benchmark: https://optimal.world/garpi/ Learn more about Optimal: https://optimal.world/ #pharmamanufacturing #assetmanagement #reliabilityengineering